RNAZ
TransCode TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
RNAZ vs peer average
48/100
RNAZ vs. peer average (F vs. F)
Grade spread
D 1 · F 6
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
INM is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $5.04M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RNAZ
TransCode Therapeutics
INM
InMed
Grade
F
F
Momentum
8
12
Value
41
58
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs INM
RNAZ / INM
Grade Position
In line
RNAZ vs. peer average (F vs. F)
48/100
Momentum
8
INMValue
41
INMSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RNAZ
INM is the first peer returned for this comparison set.

